MEDICAL SOLUTION OF THE PROBLEM OF TREATMENT OF DIABETIC ULCERS THROUGH THE PRISM OF PHARMACEUTICAL DEVELOPMENT OF TOPICALLY ACTIVE DRUGS
DOI:
https://doi.org/10.30890/2709-2313.2023-25-00-013Keywords:
diabetes, hydrogel, treatment of diabetic ulcers, topical medicineAbstract
Diabetes is the most common non-infectious disease today. In 82% of all deaths in Ukraine, their cause is non-infectious diseases. The real number of patients with type 2 diabetes in most countries is higher than the official statistics. The number of peMetrics
References
Zimmet P.Z., Magliano D.J., Herman W.H., Shaw J.E. Diabetes: a 21st century challenge//Lancet. Diabetes and Endocrinology. –2013, December. – P.5-13]
International Diabetes Federation 2011. Global Burden: Prevalence and Projections,2011 and 2030. Available from http://www.diabetesatlas.org/content/diabetes-and-impairedglucose-tolerance
Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts.// Diabetes Care. – 2003. – V.26. – P.61–69
4 Основні причини високого рівня смертності в Україні, 2010; Диабет как независимый фактор риска преждевременной смерти, 2011; IDF Diabetes Atlas, sixth edition, 2013; Hansen L.J., Olivarius N de Fi, Siesma Velkert, 2009; Seshasai S.R.,Kaptoge S.R., Thompson A., 2011; Yang X., Co G.T. C., So W.Y., 2010
Alssema M., Vistisen D, Heymans M.W. et al DETECT-2 collaboration.The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes.// Diabetologia. –2011 . –V.54. –№5. –Р.1004-1012. doi: 10.1007/s00125-010-1990-7. Epub 2010 Dec 12.
Engelgau M.M, Colagiuri S, Ramachandran A. et al. Prevention of type 2 diabetes: issues and strategies for identifying persons for interventions.//Diabetes Technol Ther. – 2004. – V.6. –P. 874–882.
Penn L, White M, Oldroyd J. et al Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK.// BMC Public Health . –2009. –№9. –P.342.
Roumen C, Corpeleijn E, Feskens E.J. et al Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study.//Diabet Med. – 2008. –V. 25. –P. 597–605.
Knowler W.C, Barrett-Connor E, Fowler S.E. et al Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.// N Engl J Med . – 2002. – V. 346. – P. 393–403.
Li G., Zhang P. Wang J. et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.// Lancet Diabetes Endocrinol. – 2014 . –V.2. –№ 6. –Р. 474-480. doi: 10.1016/S2213-8587(14)70057-9.
Gillies C.L, Abrams K.R, Lambert P.C et al.Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis.//BMJ . –2007. –V.334. –P.299–308.
Dunbar J.A., Hernan A.L.,, Janus E.D. et al.Challenges of diabetes prevention in the real world: lesults and lessons from the Melbourne Diabetes Prevention Study.// BMJ Open Diabetes Res Care. – 2015 . –V. 3. – №1:e000131. doi: 10.1136/bmjdrc-2015-000131. eCollection 2015.
Simmons R.K, van den Donk M,Wareham N/J, Lauritzen T. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial.//Lancet. – 2011. –V.378. –P.156–167.
Christensen D.L, Witte D.R, Kaduka L. et al. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups.// Diabetes Care. – 2010. –V. 33. –P. 580–582.
Pani L.N, Korenda L, Meigs J.B. et al Effect of aging on A1C levels in individuals without diabetes:evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001–2004.// Diabetes Care. – 2008. –V. 31. –P. 1991–1996
World Health Organization (WHO) Consultation. Definition and diagnosis of diabetes and intermediate hyperglycaemia. 2006 http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf.Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35 Suppl 1: S64-71.
Gillies C., Abrams K., Lambert P., 2007; Jeon C.V., Lokken R.P., Hu F.F., van Dam R.M., 2007
Age and sexspecific prevalences of diabetes and impaired glucose regulation in 13 European cohorts// Diabetes Care. – 2003.V – 26. – P.61–69
Pani L.N., Korenda L., Meigs J.B. et al. Effect of aging on A1Cl levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001 – 2004 // Diabetes Care. – 2008. –V .31. – P.1991–1996
Iryna Vlasenko, Lena Davtian Study of the influence of armed conflict on the reimbursement of oral glucose lowering drugs in Ukraine // Pharmacia, 70(2): 275–281 DOI 10.3897/pharmacia.70.e99657
Study of pharmaceutical provision of type 2 diabetes therapy in Ukraine.IO Vlasenko, LL Davtian, ОM Zaliska - Pharmaceutical Review/Farmacevtičnij časopis, 2022 (2). – 12 - 20 (https://doi.org/10.11603/2312-0967.2022.2.13332)
Сучасні аспекти лікування ранового процесу із застосуванням покриттів (пов’язок) ОП Шматенко, ЛЛ Давтян, ТВ Приходько /Запорізький медичний журнал, 2022. - Vol. 24 No. 5 . – 599-606
Коритнюк РС, Загорій ГВ, Тарасенко ВО, Укадіке Ч. Технологія та фізикохімічна характеричтика гелів. Фармацевтичний журнал. 2012;3:38-42.
Орищенко, А. Ю. Гелі, як м’яка лікарська форма для зовнішнього застосування / А. Ю. Орищенко,Т. Г. Ярних, С. В. Олійник // Технологічні та біофармацевтичні аспекти створення лікарських препаратів різної направленості дії : матеріали VI Міжнар. наук.-практ. інтернет-конф., м. Харків, 11-12 листоп. 2021 р. - Харків : Вид-во НФаУ, 2021. - С. 408-410.
Гладышев В.В., Давтян Л.Л., Дроздов А.Л., Бирюк И.А., Кечин И.Л. Биофармация. Учебник для фармацевтических вузов и факультетов. 2-е изд. Под редакцией В.В. Гладышева. Днипро: ЧМП «Экономика». 2018.- 250 с
Декаметоксин і хлоргексидин на вітчизняному фармацевтичному ринку / Л. Л. Давтян, В. П. Попович, З. В. Малецька, Д. В. Рева // Фармацевтичний журнал. - 2014. - № 1. - С. 28-33. - Режим доступу: http://nbuv.gov.ua/UJRN/pharmazh_2014_1_4
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
